Skip to Main Content

Paper Details

Integrated RNA and metabolite profiling of urine liquid biopsies for prostate cancer biomarker discovery.
Sci Rep
35
2020
GOT1, PCa, RNA, TCA, benign and malignant disease, benign prostatic disease, cancer, glutamate, glutamate oxaloacetate, glutamate oxaloacetate transaminase 1, mRNA, patients, prostate cancer, prostate cancer-derived cells, prostate-derived cancer, prostate-derived cancer cells, tricarboxylic acid, urinary RNAs, urinary gene, urine, urine-enriched RNAs
Author NameAffiliation
Fubo WangShanghai Changhai Hospital, Second Military Medical University
Christian P PavlovichThe James Buchanan Brady Urological Institute, The Johns Hopkins University School of Medicine
Gary P SchrothInc.
Ranjan J PereraCancer and Blood Disorders Institute, Johns Hopkins All Children's Hospital
Ranjan J PereraSydney Kimmel Cancer Center, Johns Hopkins University School of Medicine
Ranjan J PereraSanford Burnham Prebys Medical Discovery Institute
  • 1 - 6

Datasets

Release 1.2